

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.92691223 |
| 2 | drug transmembrane transport (GO:0006855) | 9.10253131 |
| 3 | urate metabolic process (GO:0046415) | 8.94769230 |
| 4 | drug transport (GO:0015893) | 7.61886374 |
| 5 | organic cation transport (GO:0015695) | 7.51686858 |
| 6 | phosphate ion transport (GO:0006817) | 6.83181648 |
| 7 | lysine metabolic process (GO:0006553) | 5.92725716 |
| 8 | lysine catabolic process (GO:0006554) | 5.92725716 |
| 9 | exogenous drug catabolic process (GO:0042738) | 5.87814950 |
| 10 | drug catabolic process (GO:0042737) | 5.74792699 |
| 11 | sodium-independent organic anion transport (GO:0043252) | 5.68922312 |
| 12 | quaternary ammonium group transport (GO:0015697) | 5.63479288 |
| 13 | excretion (GO:0007588) | 5.40392598 |
| 14 | response to mercury ion (GO:0046689) | 5.39482123 |
| 15 | phosphate ion transmembrane transport (GO:0035435) | 5.32332467 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.20350706 |
| 17 | toxin transport (GO:1901998) | 5.08677093 |
| 18 | vitamin D metabolic process (GO:0042359) | 4.95803117 |
| 19 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.88941951 |
| 20 | oligosaccharide catabolic process (GO:0009313) | 4.85996057 |
| 21 | metanephric tubule development (GO:0072170) | 4.81285009 |
| 22 | metanephric nephron tubule development (GO:0072234) | 4.81285009 |
| 23 | renal absorption (GO:0070293) | 4.80488977 |
| 24 | trivalent inorganic anion homeostasis (GO:0072506) | 4.73198942 |
| 25 | phosphate ion homeostasis (GO:0055062) | 4.73198942 |
| 26 | metanephric nephron epithelium development (GO:0072243) | 4.52026673 |
| 27 | short-chain fatty acid metabolic process (GO:0046459) | 4.45560152 |
| 28 | branched-chain amino acid metabolic process (GO:0009081) | 4.44947435 |
| 29 | modified amino acid transport (GO:0072337) | 4.44690924 |
| 30 | glycoside metabolic process (GO:0016137) | 4.43932136 |
| 31 | tricarboxylic acid metabolic process (GO:0072350) | 4.42691444 |
| 32 | cysteine metabolic process (GO:0006534) | 4.31968535 |
| 33 | glutathione biosynthetic process (GO:0006750) | 4.30990006 |
| 34 | metanephric epithelium development (GO:0072207) | 4.19508002 |
| 35 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.17314358 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 4.17103371 |
| 37 | membrane repolarization during action potential (GO:0086011) | 4.10696080 |
| 38 | actin filament depolymerization (GO:0030042) | 3.94863293 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.93638325 |
| 40 | L-phenylalanine catabolic process (GO:0006559) | 3.93638325 |
| 41 | nephron tubule development (GO:0072080) | 3.85822260 |
| 42 | nephron epithelium morphogenesis (GO:0072088) | 3.81226090 |
| 43 | nephron tubule morphogenesis (GO:0072078) | 3.81226090 |
| 44 | polyol transport (GO:0015791) | 3.80820892 |
| 45 | tryptophan metabolic process (GO:0006568) | 3.80357664 |
| 46 | auditory receptor cell differentiation (GO:0042491) | 3.79519162 |
| 47 | aromatic amino acid family catabolic process (GO:0009074) | 3.79022674 |
| 48 | L-phenylalanine metabolic process (GO:0006558) | 3.74734228 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.74734228 |
| 50 | peptide biosynthetic process (GO:0043043) | 3.74475208 |
| 51 | branched-chain amino acid catabolic process (GO:0009083) | 3.71519323 |
| 52 | carnitine transport (GO:0015879) | 3.70920580 |
| 53 | amino-acid betaine transport (GO:0015838) | 3.70920580 |
| 54 | peptide catabolic process (GO:0043171) | 3.68798152 |
| 55 | indole-containing compound catabolic process (GO:0042436) | 3.66207675 |
| 56 | indolalkylamine catabolic process (GO:0046218) | 3.66207675 |
| 57 | tryptophan catabolic process (GO:0006569) | 3.66207675 |
| 58 | bicarbonate transport (GO:0015701) | 3.63552768 |
| 59 | valine metabolic process (GO:0006573) | 3.62796628 |
| 60 | vitamin transport (GO:0051180) | 3.61681360 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.53860543 |
| 62 | homocysteine metabolic process (GO:0050667) | 3.51515124 |
| 63 | indole-containing compound metabolic process (GO:0042430) | 3.51468341 |
| 64 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49909079 |
| 65 | proline metabolic process (GO:0006560) | 3.47613905 |
| 66 | sodium ion transport (GO:0006814) | 3.47112116 |
| 67 | righting reflex (GO:0060013) | 3.46481459 |
| 68 | renal tubule development (GO:0061326) | 3.45877776 |
| 69 | sulfur compound transport (GO:0072348) | 3.41025463 |
| 70 | response to parathyroid hormone (GO:0071107) | 3.39074389 |
| 71 | collecting duct development (GO:0072044) | 3.38188621 |
| 72 | vasodilation (GO:0042311) | 3.33989749 |
| 73 | cardiovascular system development (GO:0072358) | 3.31910310 |
| 74 | positive regulation of gluconeogenesis (GO:0045722) | 3.27567890 |
| 75 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.27239490 |
| 76 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.26508813 |
| 77 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.25389142 |
| 78 | nephron epithelium development (GO:0072009) | 3.22781958 |
| 79 | fatty acid beta-oxidation (GO:0006635) | 3.22370037 |
| 80 | fructose metabolic process (GO:0006000) | 3.19491924 |
| 81 | endothelium development (GO:0003158) | 3.19302891 |
| 82 | cell volume homeostasis (GO:0006884) | 3.19293581 |
| 83 | serine family amino acid catabolic process (GO:0009071) | 3.14550353 |
| 84 | negative regulation of complement activation (GO:0045916) | 3.14057673 |
| 85 | detection of calcium ion (GO:0005513) | 3.13029716 |
| 86 | sphingomyelin metabolic process (GO:0006684) | 3.12854303 |
| 87 | peptide hormone processing (GO:0016486) | 3.08392254 |
| 88 | renal tubule morphogenesis (GO:0061333) | 3.06813282 |
| 89 | response to magnesium ion (GO:0032026) | 3.06122514 |
| 90 | glutathione metabolic process (GO:0006749) | 3.05248582 |
| 91 | cellular response to vitamin D (GO:0071305) | 3.04747772 |
| 92 | amino-acid betaine metabolic process (GO:0006577) | 3.04499703 |
| 93 | potassium ion import (GO:0010107) | 3.01742504 |
| 94 | fatty acid oxidation (GO:0019395) | 3.01694284 |
| 95 | brain morphogenesis (GO:0048854) | 3.00400338 |
| 96 | glycerophospholipid catabolic process (GO:0046475) | 2.98245628 |
| 97 | heparin biosynthetic process (GO:0030210) | 2.97694274 |
| 98 | heparin metabolic process (GO:0030202) | 2.97694274 |
| 99 | lipid oxidation (GO:0034440) | 2.97062996 |
| 100 | inositol metabolic process (GO:0006020) | 2.96151914 |
| 101 | indolalkylamine metabolic process (GO:0006586) | 2.95963376 |
| 102 | basic amino acid transport (GO:0015802) | 2.94358852 |
| 103 | neurotransmitter biosynthetic process (GO:0042136) | 2.92379938 |
| 104 | response to phenylpropanoid (GO:0080184) | 2.92153191 |
| 105 | biotin metabolic process (GO:0006768) | 2.91882790 |
| 106 | cobalamin metabolic process (GO:0009235) | 2.91795929 |
| 107 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.89904015 |
| 108 | polyol catabolic process (GO:0046174) | 2.88020734 |
| 109 | regulation of calcium ion import (GO:0090279) | 2.87272236 |
| 110 | aromatic amino acid family metabolic process (GO:0009072) | 2.87015891 |
| 111 | response to lipoprotein particle (GO:0055094) | 2.86647740 |
| 112 | cellular ketone body metabolic process (GO:0046950) | 2.85674261 |
| 113 | serine family amino acid metabolic process (GO:0009069) | 2.85091841 |
| 114 | membrane repolarization (GO:0086009) | 2.84997780 |
| 115 | vitamin transmembrane transport (GO:0035461) | 2.84983479 |
| 116 | mitochondrion distribution (GO:0048311) | 2.84905626 |
| 117 | sulfate transport (GO:0008272) | 2.84356371 |
| 118 | carnitine metabolic process (GO:0009437) | 2.84045928 |
| 119 | response to lead ion (GO:0010288) | 2.83564774 |
| 120 | transepithelial transport (GO:0070633) | 2.81453430 |
| 121 | positive regulation of calcium ion import (GO:0090280) | 2.80352943 |
| 122 | cellular amino acid catabolic process (GO:0009063) | 2.78925917 |
| 123 | inorganic anion transport (GO:0015698) | 2.77576223 |
| 124 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.76880183 |
| 125 | response to thyroid hormone (GO:0097066) | 2.75560053 |
| 126 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.75297620 |
| 127 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.75170320 |
| 128 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.74711421 |
| 129 | 2-oxoglutarate metabolic process (GO:0006103) | 2.73072115 |
| 130 | artery smooth muscle contraction (GO:0014824) | 2.72605724 |
| 131 | negative regulation of protein activation cascade (GO:2000258) | 2.71048517 |
| 132 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.70530749 |
| 133 | insulin secretion (GO:0030073) | 2.68129590 |
| 134 | phospholipid dephosphorylation (GO:0046839) | 2.67553992 |
| 135 | endocrine pancreas development (GO:0031018) | 2.67260146 |
| 136 | chemosensory behavior (GO:0007635) | 2.66943273 |
| 137 | positive regulation of vasculogenesis (GO:2001214) | 2.66671525 |
| 138 | nodal signaling pathway (GO:0038092) | 2.66159966 |
| 139 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.65802534 |
| 140 | positive regulation of glomerulus development (GO:0090193) | 2.64984695 |
| 141 | positive regulation of heat generation (GO:0031652) | 2.63855879 |
| 142 | cell differentiation involved in metanephros development (GO:0072202) | 2.63649089 |
| 143 | positive regulation of catenin import into nucleus (GO:0035413) | 2.61602331 |
| 144 | tonic smooth muscle contraction (GO:0014820) | 2.57582069 |
| 145 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.57345566 |
| 146 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.56208482 |
| 147 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.51321010 |
| 148 | regulation of Rac protein signal transduction (GO:0035020) | 2.49970942 |
| 149 | positive regulation of glucose metabolic process (GO:0010907) | 2.49274313 |
| 150 | epithelial cell fate commitment (GO:0072148) | 2.46984813 |
| 151 | iron ion import (GO:0097286) | 2.45855527 |
| 152 | regulation of protein localization to cell surface (GO:2000008) | 2.43028334 |
| 153 | glomerular visceral epithelial cell development (GO:0072015) | 2.42902076 |
| 154 | regulation of fever generation (GO:0031620) | 2.40922429 |
| 155 | positive regulation of glycogen metabolic process (GO:0070875) | 2.40114007 |
| 156 | cellular potassium ion homeostasis (GO:0030007) | 2.39968676 |
| 157 | endosome to melanosome transport (GO:0035646) | 2.39845534 |
| 158 | endosome to pigment granule transport (GO:0043485) | 2.39845534 |
| 159 | response to copper ion (GO:0046688) | 2.39743049 |
| 160 | positive regulation of carbohydrate metabolic process (GO:0045913) | 2.39194423 |
| 161 | renal system process (GO:0003014) | 2.36366797 |
| 162 | potassium ion homeostasis (GO:0055075) | 2.36338539 |
| 163 | relaxation of cardiac muscle (GO:0055119) | 2.35771495 |
| 164 | negative regulation of metanephros development (GO:0072217) | 2.35232508 |
| 165 | negative regulation of humoral immune response (GO:0002921) | 2.35051260 |
| 166 | nephron tubule formation (GO:0072079) | 2.33801031 |
| 167 | nitric oxide biosynthetic process (GO:0006809) | 2.33593667 |
| 168 | toxin metabolic process (GO:0009404) | 2.33282159 |
| 169 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.32789642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.12126702 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.02927265 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.62961499 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.50445744 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18681969 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.16473063 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.13720594 |
| 8 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.94371893 |
| 9 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.92205517 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.90275003 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86211906 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.83288525 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.81506231 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80824117 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.76869776 |
| 16 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70915672 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.70724719 |
| 18 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.69391434 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.67220274 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64348372 |
| 21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63693100 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60119514 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.57885406 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.56708597 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54110971 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53689072 |
| 27 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.50886359 |
| 28 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.50886359 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47710824 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46202317 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44561438 |
| 32 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.42607408 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41495945 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41277907 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41145335 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39844445 |
| 37 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.38985839 |
| 38 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36461215 |
| 39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36379957 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36094215 |
| 41 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35996282 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34793538 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34029087 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32555738 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32348898 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32258761 |
| 47 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.32154088 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.31574062 |
| 49 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31536434 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31244150 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29797224 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28922055 |
| 53 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.26674227 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26319559 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.25727958 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24973723 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24839302 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23943779 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22456792 |
| 60 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.22360952 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21240433 |
| 62 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.21193565 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20421490 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19725688 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19315864 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19002921 |
| 67 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18655627 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18625509 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18452996 |
| 70 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.17929734 |
| 71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17223681 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17155955 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17155955 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16510425 |
| 75 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16458160 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15813403 |
| 77 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15749416 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15478435 |
| 79 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14325769 |
| 80 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13990690 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13032762 |
| 82 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.12947464 |
| 83 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10370588 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09807183 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08727036 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07552357 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07449926 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06264213 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04960595 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04909427 |
| 91 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04511815 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04402922 |
| 93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04324814 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04161406 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04142200 |
| 96 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.03990766 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03282970 |
| 98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02209229 |
| 99 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01599771 |
| 100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01476398 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01170860 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00802569 |
| 103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00750621 |
| 104 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99603419 |
| 105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99117174 |
| 106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99113129 |
| 107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99043230 |
| 108 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98983307 |
| 109 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97858019 |
| 110 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97638390 |
| 111 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97436585 |
| 112 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97111723 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97071039 |
| 114 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96576165 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96169542 |
| 116 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96009178 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95849192 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95208547 |
| 119 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.95019083 |
| 120 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94923222 |
| 121 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94916329 |
| 122 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.93648132 |
| 123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93579683 |
| 124 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93553755 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92677265 |
| 126 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92614892 |
| 127 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92571423 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92388454 |
| 129 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.91855174 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.91632143 |
| 131 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.91520847 |
| 132 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90802333 |
| 133 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.90741325 |
| 134 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89630278 |
| 135 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.89470942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 6.92823995 |
| 2 | MP0005360_urolithiasis | 5.59663394 |
| 3 | * MP0004019_abnormal_vitamin_homeostasis | 4.90644512 |
| 4 | MP0005332_abnormal_amino_acid | 4.53381513 |
| 5 | MP0003195_calcinosis | 4.12381871 |
| 6 | * MP0001765_abnormal_ion_homeostasis | 3.87309962 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.79235421 |
| 8 | MP0009643_abnormal_urine_homeostasis | 3.69081911 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.32819572 |
| 10 | MP0005636_abnormal_mineral_homeostasis | 3.05672826 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.95238615 |
| 12 | MP0001756_abnormal_urination | 2.84356851 |
| 13 | MP0002136_abnormal_kidney_physiology | 2.79850173 |
| 14 | MP0008004_abnormal_stomach_pH | 2.72475470 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.59101887 |
| 16 | MP0003878_abnormal_ear_physiology | 2.52083272 |
| 17 | MP0005377_hearing/vestibular/ear_phenot | 2.52083272 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.42183843 |
| 19 | MP0003011_delayed_dark_adaptation | 2.36125993 |
| 20 | MP0003252_abnormal_bile_duct | 2.18525244 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.16021473 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.90259057 |
| 23 | MP0004885_abnormal_endolymph | 1.86553805 |
| 24 | MP0010368_abnormal_lymphatic_system | 1.79663967 |
| 25 | MP0002928_abnormal_bile_duct | 1.78306878 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.78226082 |
| 27 | MP0000538_abnormal_urinary_bladder | 1.76382263 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.76217632 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.71978395 |
| 30 | MP0002254_reproductive_system_inflammat | 1.61183331 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.61105447 |
| 32 | MP0008961_abnormal_basal_metabolism | 1.51839284 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.51227229 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.50865697 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.45681996 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41602359 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.38386795 |
| 38 | MP0000230_abnormal_systemic_arterial | 1.37747973 |
| 39 | MP0005367_renal/urinary_system_phenotyp | 1.36850516 |
| 40 | MP0000516_abnormal_urinary_system | 1.36850516 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.31013900 |
| 42 | MP0001879_abnormal_lymphatic_vessel | 1.29787980 |
| 43 | * MP0002693_abnormal_pancreas_physiology | 1.29252094 |
| 44 | MP0005451_abnormal_body_composition | 1.23228671 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.23065971 |
| 46 | * MP0001958_emphysema | 1.21958471 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.19634222 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.18453329 |
| 49 | MP0003045_fibrosis | 1.15987966 |
| 50 | MP0004742_abnormal_vestibular_system | 1.14957892 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.13188871 |
| 52 | * MP0005535_abnormal_body_temperature | 1.11256652 |
| 53 | MP0001764_abnormal_homeostasis | 1.09789530 |
| 54 | MP0005310_abnormal_salivary_gland | 1.09375031 |
| 55 | * MP0002971_abnormal_brown_adipose | 1.07193060 |
| 56 | MP0005365_abnormal_bile_salt | 1.07100207 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.06975921 |
| 58 | MP0001270_distended_abdomen | 1.05770385 |
| 59 | MP0005448_abnormal_energy_balance | 1.05491511 |
| 60 | MP0001963_abnormal_hearing_physiology | 1.04049237 |
| 61 | MP0006054_spinal_hemorrhage | 1.00931598 |
| 62 | MP0004510_myositis | 1.00858159 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.00194044 |
| 64 | MP0005670_abnormal_white_adipose | 0.99728984 |
| 65 | MP0002896_abnormal_bone_mineralization | 0.97417693 |
| 66 | MP0000920_abnormal_myelination | 0.95428223 |
| 67 | MP0002735_abnormal_chemical_nociception | 0.95281458 |
| 68 | MP0002064_seizures | 0.94333052 |
| 69 | MP0003950_abnormal_plasma_membrane | 0.93436558 |
| 70 | MP0004147_increased_porphyrin_level | 0.91430754 |
| 71 | MP0004859_abnormal_synaptic_plasticity | 0.90172551 |
| 72 | MP0002135_abnormal_kidney_morphology | 0.89028340 |
| 73 | * MP0003186_abnormal_redox_activity | 0.87505015 |
| 74 | MP0000383_abnormal_hair_follicle | 0.87318285 |
| 75 | MP0001664_abnormal_digestion | 0.87157880 |
| 76 | MP0003879_abnormal_hair_cell | 0.86844039 |
| 77 | MP0000678_abnormal_parathyroid_gland | 0.86593671 |
| 78 | MP0003283_abnormal_digestive_organ | 0.84902355 |
| 79 | MP0003646_muscle_fatigue | 0.84651420 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.84183437 |
| 81 | MP0001661_extended_life_span | 0.81900107 |
| 82 | MP0009046_muscle_twitch | 0.81605104 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 0.81504268 |
| 84 | MP0009745_abnormal_behavioral_response | 0.80849803 |
| 85 | MP0003638_abnormal_response/metabolism_ | 0.79758612 |
| 86 | MP0002938_white_spotting | 0.78409067 |
| 87 | MP0002163_abnormal_gland_morphology | 0.78187057 |
| 88 | MP0003329_amyloid_beta_deposits | 0.77422745 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.77272819 |
| 90 | MP0003868_abnormal_feces_composition | 0.75992577 |
| 91 | * MP0002168_other_aberrant_phenotype | 0.75163278 |
| 92 | MP0001177_atelectasis | 0.73982041 |
| 93 | * MP0003633_abnormal_nervous_system | 0.73405123 |
| 94 | MP0009840_abnormal_foam_cell | 0.73385432 |
| 95 | MP0003690_abnormal_glial_cell | 0.72575151 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.72348144 |
| 97 | MP0001984_abnormal_olfaction | 0.71476964 |
| 98 | MP0002067_abnormal_sensory_capabilities | 0.71335096 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.71315635 |
| 100 | MP0005408_hypopigmentation | 0.71282131 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.71187349 |
| 102 | MP0003303_peritoneal_inflammation | 0.69893890 |
| 103 | MP0004142_abnormal_muscle_tone | 0.69280975 |
| 104 | MP0003122_maternal_imprinting | 0.68723645 |
| 105 | MP0001486_abnormal_startle_reflex | 0.68300076 |
| 106 | MP0004085_abnormal_heartbeat | 0.68058386 |
| 107 | MP0000371_diluted_coat_color | 0.68023998 |
| 108 | * MP0003953_abnormal_hormone_level | 0.66669893 |
| 109 | MP0001440_abnormal_grooming_behavior | 0.66566763 |
| 110 | MP0004484_altered_response_of | 0.66285228 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.65894879 |
| 112 | MP0002118_abnormal_lipid_homeostasis | 0.65323242 |
| 113 | * MP0005375_adipose_tissue_phenotype | 0.64662033 |
| 114 | MP0004270_analgesia | 0.64553015 |
| 115 | MP0005620_abnormal_muscle_contractility | 0.63569331 |
| 116 | MP0009764_decreased_sensitivity_to | 0.63463628 |
| 117 | MP0005330_cardiomyopathy | 0.63417355 |
| 118 | MP0000026_abnormal_inner_ear | 0.62206594 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.61113623 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.60902911 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 0.59317841 |
| 122 | MP0003959_abnormal_lean_body | 0.59081256 |
| 123 | MP0003787_abnormal_imprinting | 0.58029583 |
| 124 | MP0004924_abnormal_behavior | 0.57482059 |
| 125 | MP0005386_behavior/neurological_phenoty | 0.57482059 |
| 126 | MP0005165_increased_susceptibility_to | 0.56600623 |
| 127 | * MP0005395_other_phenotype | 0.56510967 |
| 128 | MP0005452_abnormal_adipose_tissue | 0.56334272 |
| 129 | MP0003635_abnormal_synaptic_transmissio | 0.54939662 |
| 130 | * MP0002229_neurodegeneration | 0.54322513 |
| 131 | MP0002272_abnormal_nervous_system | 0.53763875 |
| 132 | MP0004272_abnormal_basement_membrane | 0.52255506 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.51834111 |
| 134 | * MP0002078_abnormal_glucose_homeostasis | 0.51480924 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.51010864 |
| 136 | MP0002572_abnormal_emotion/affect_behav | 0.50786753 |
| 137 | MP0002066_abnormal_motor_capabilities/c | 0.49842618 |
| 138 | MP0005409_darkened_coat_color | 0.49645351 |
| 139 | MP0003191_abnormal_cellular_cholesterol | 0.49137625 |
| 140 | MP0000372_irregular_coat_pigmentation | 0.48592320 |
| 141 | MP0000778_abnormal_nervous_system | 0.48419835 |
| 142 | MP0002734_abnormal_mechanical_nocicepti | 0.48281576 |
| 143 | MP0002295_abnormal_pulmonary_circulatio | 0.48224356 |
| 144 | * MP0001944_abnormal_pancreas_morphology | 0.48207464 |
| 145 | MP0005167_abnormal_blood-brain_barrier | 0.47129796 |
| 146 | MP0008469_abnormal_protein_level | 0.45897670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 8.25762911 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 7.59647283 |
| 3 | Metabolic alkalosis (HP:0200114) | 7.38487201 |
| 4 | Hypomagnesemia (HP:0002917) | 7.01106226 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.91692816 |
| 6 | Polyuria (HP:0000103) | 6.54989831 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 6.31965455 |
| 8 | Abnormal urine output (HP:0012590) | 6.18453875 |
| 9 | Abnormality of magnesium homeostasis (HP:0004921) | 5.93943253 |
| 10 | Gout (HP:0001997) | 5.77471022 |
| 11 | * Abnormality of renal excretion (HP:0011036) | 5.55386640 |
| 12 | Abnormal drinking behavior (HP:0030082) | 5.50966536 |
| 13 | Polydipsia (HP:0001959) | 5.50966536 |
| 14 | Abnormality of renin-angiotensin system (HP:0000847) | 5.24387955 |
| 15 | Proximal tubulopathy (HP:0000114) | 5.05428253 |
| 16 | Tetany (HP:0001281) | 4.92793528 |
| 17 | Hyperaldosteronism (HP:0000859) | 4.89718963 |
| 18 | Alkalosis (HP:0001948) | 4.77353074 |
| 19 | Hyperuricemia (HP:0002149) | 4.70070615 |
| 20 | Increased purine levels (HP:0004368) | 4.70070615 |
| 21 | Renal salt wasting (HP:0000127) | 4.64922289 |
| 22 | Generalized aminoaciduria (HP:0002909) | 4.31197986 |
| 23 | * Hyperphosphatemia (HP:0002905) | 4.14906266 |
| 24 | Hypokalemia (HP:0002900) | 4.09031436 |
| 25 | Abnormality of purine metabolism (HP:0004352) | 3.97157911 |
| 26 | Hyperglycinuria (HP:0003108) | 3.88658906 |
| 27 | Hypercalciuria (HP:0002150) | 3.79529961 |
| 28 | Glycosuria (HP:0003076) | 3.77865136 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 3.77865136 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.64304519 |
| 31 | Abnormality of potassium homeostasis (HP:0011042) | 3.54040027 |
| 32 | Ketoacidosis (HP:0001993) | 3.46399939 |
| 33 | Tubular atrophy (HP:0000092) | 3.40193554 |
| 34 | Renal tubular acidosis (HP:0001947) | 3.34002752 |
| 35 | Hyperphosphaturia (HP:0003109) | 3.18709926 |
| 36 | Abnormal urine phosphate concentration (HP:0012599) | 3.08842527 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.05244785 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.05244785 |
| 39 | Delayed epiphyseal ossification (HP:0002663) | 2.93979480 |
| 40 | Ketosis (HP:0001946) | 2.77348899 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77129524 |
| 42 | Hypophosphatemia (HP:0002148) | 2.74132083 |
| 43 | * Nephrocalcinosis (HP:0000121) | 2.72346189 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 2.61492053 |
| 45 | Widely patent fontanelles and sutures (HP:0004492) | 2.53229863 |
| 46 | Renal tubular dysfunction (HP:0000124) | 2.52462455 |
| 47 | Hyponatremia (HP:0002902) | 2.51878826 |
| 48 | Rickets (HP:0002748) | 2.47534041 |
| 49 | Enlarged kidneys (HP:0000105) | 2.46692606 |
| 50 | Hydroxyprolinuria (HP:0003080) | 2.45962775 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 2.45962775 |
| 52 | Nephrolithiasis (HP:0000787) | 2.44629384 |
| 53 | Decreased circulating renin level (HP:0003351) | 2.42729927 |
| 54 | Abnormality of sodium homeostasis (HP:0010931) | 2.41933430 |
| 55 | Dehydration (HP:0001944) | 2.38601562 |
| 56 | Hypotension (HP:0002615) | 2.36305385 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34843769 |
| 58 | Abnormality of vitamin B metabolism (HP:0004340) | 2.34388142 |
| 59 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.32853362 |
| 60 | Urethral obstruction (HP:0000796) | 2.30474480 |
| 61 | * Abnormality of renal resorption (HP:0011038) | 2.24988301 |
| 62 | Adrenal overactivity (HP:0002717) | 2.16514609 |
| 63 | Hypoplasia of the uterus (HP:0000013) | 2.15215452 |
| 64 | Abnormality of vitamin metabolism (HP:0100508) | 2.12152855 |
| 65 | Hyperkalemia (HP:0002153) | 2.11931919 |
| 66 | Delayed CNS myelination (HP:0002188) | 2.11733965 |
| 67 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.09927625 |
| 68 | Large eyes (HP:0001090) | 2.08446707 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.07865536 |
| 70 | Confusion (HP:0001289) | 2.07580141 |
| 71 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.04916041 |
| 72 | Metaphyseal irregularity (HP:0003025) | 2.03566425 |
| 73 | Hypothermia (HP:0002045) | 2.01850024 |
| 74 | J-shaped sella turcica (HP:0002680) | 2.00601774 |
| 75 | Methylmalonic aciduria (HP:0012120) | 1.98945135 |
| 76 | Potter facies (HP:0002009) | 1.98433265 |
| 77 | Facial shape deformation (HP:0011334) | 1.98433265 |
| 78 | Increased CSF protein (HP:0002922) | 1.98210140 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95666266 |
| 80 | Hyperglycinemia (HP:0002154) | 1.91306387 |
| 81 | Large for gestational age (HP:0001520) | 1.91111807 |
| 82 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90861493 |
| 83 | Vomiting (HP:0002013) | 1.90505461 |
| 84 | Septate vagina (HP:0001153) | 1.88876035 |
| 85 | Hypophosphatemic rickets (HP:0004912) | 1.88690271 |
| 86 | Metabolic acidosis (HP:0001942) | 1.87821538 |
| 87 | Abnormality of the costochondral junction (HP:0000919) | 1.86636406 |
| 88 | Hypoparathyroidism (HP:0000829) | 1.86081419 |
| 89 | Axonal loss (HP:0003447) | 1.85307889 |
| 90 | Abnormal pancreas size (HP:0012094) | 1.84788898 |
| 91 | Metaphyseal dysplasia (HP:0100255) | 1.84526647 |
| 92 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82890656 |
| 93 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82719300 |
| 94 | Fair hair (HP:0002286) | 1.82660103 |
| 95 | Bicornuate uterus (HP:0000813) | 1.81781805 |
| 96 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81077923 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 1.81077923 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 1.77548746 |
| 99 | Metaphyseal cupping (HP:0003021) | 1.76846072 |
| 100 | Tetraparesis (HP:0002273) | 1.76426378 |
| 101 | Tubulointerstitial abnormality (HP:0001969) | 1.74647779 |
| 102 | Lethargy (HP:0001254) | 1.73969585 |
| 103 | Abnormal eating behavior (HP:0100738) | 1.71519460 |
| 104 | Mucopolysacchariduria (HP:0008155) | 1.70868795 |
| 105 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.70868795 |
| 106 | Abnormality of Sharpey fibers (HP:0100685) | 1.69980650 |
| 107 | Polyphagia (HP:0002591) | 1.68339598 |
| 108 | Tubulointerstitial fibrosis (HP:0005576) | 1.68287964 |
| 109 | Chondrocalcinosis (HP:0000934) | 1.68183582 |
| 110 | Abnormal tarsal ossification (HP:0008369) | 1.67685011 |
| 111 | Tachypnea (HP:0002789) | 1.67605515 |
| 112 | Generalized muscle weakness (HP:0003324) | 1.67471484 |
| 113 | Hyperventilation (HP:0002883) | 1.66839015 |
| 114 | Persistence of primary teeth (HP:0006335) | 1.65596783 |
| 115 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.64693438 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63750989 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63750989 |
| 118 | Abnormality of the renal cortex (HP:0011035) | 1.61481219 |
| 119 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.61320263 |
| 120 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.61320263 |
| 121 | Abnormality of glycolipid metabolism (HP:0010969) | 1.61320263 |
| 122 | Hypocalcemia (HP:0002901) | 1.59850676 |
| 123 | Nuclear cataract (HP:0100018) | 1.53995624 |
| 124 | Abnormality of the renal medulla (HP:0100957) | 1.52125032 |
| 125 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.50198107 |
| 126 | Progressive neurologic deterioration (HP:0002344) | 1.45599393 |
| 127 | Volvulus (HP:0002580) | 1.42084973 |
| 128 | Generalized hypopigmentation of hair (HP:0011358) | 1.41983863 |
| 129 | Methylmalonic acidemia (HP:0002912) | 1.41426687 |
| 130 | Agitation (HP:0000713) | 1.39327549 |
| 131 | Hypoalbuminemia (HP:0003073) | 1.38563119 |
| 132 | Abnormal albumin level (HP:0012116) | 1.38563119 |
| 133 | Cardiomegaly (HP:0001640) | 1.36489311 |
| 134 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.34972828 |
| 135 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.34886490 |
| 136 | Growth hormone excess (HP:0000845) | 1.34279012 |
| 137 | Intestinal atresia (HP:0011100) | 1.33429957 |
| 138 | Albinism (HP:0001022) | 1.32662413 |
| 139 | Conjugated hyperbilirubinemia (HP:0002908) | 1.32038909 |
| 140 | Prominent supraorbital ridges (HP:0000336) | 1.31501033 |
| 141 | Exotropia (HP:0000577) | 1.31243813 |
| 142 | Mitral stenosis (HP:0001718) | 1.29547087 |
| 143 | Zonular cataract (HP:0010920) | 1.29274145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 9.53363811 |
| 2 | OXSR1 | 6.99276573 |
| 3 | WNK3 | 6.49974819 |
| 4 | STK39 | 6.17423774 |
| 5 | WNK1 | 2.37370193 |
| 6 | ACVR1B | 2.06659586 |
| 7 | KDR | 2.05942403 |
| 8 | MAPK15 | 1.84912428 |
| 9 | SGK494 | 1.79118873 |
| 10 | SGK223 | 1.79118873 |
| 11 | STK38L | 1.59495782 |
| 12 | BCKDK | 1.41236105 |
| 13 | MST4 | 1.34458292 |
| 14 | INSRR | 1.31399439 |
| 15 | DAPK2 | 1.29720757 |
| 16 | MAP2K6 | 1.28173593 |
| 17 | MAP3K3 | 1.22302098 |
| 18 | MAP3K2 | 1.19887270 |
| 19 | FGFR3 | 1.13876321 |
| 20 | SGK2 | 1.05818330 |
| 21 | NLK | 1.03275317 |
| 22 | MAP4K2 | 1.03246579 |
| 23 | STK24 | 1.00639927 |
| 24 | MAP3K6 | 0.97618440 |
| 25 | TRPM7 | 0.97344269 |
| 26 | TGFBR2 | 0.91930946 |
| 27 | EPHA4 | 0.91009215 |
| 28 | MYLK | 0.90580053 |
| 29 | STK38 | 0.89435063 |
| 30 | PHKG1 | 0.87888644 |
| 31 | PHKG2 | 0.87888644 |
| 32 | EPHB1 | 0.87457128 |
| 33 | TESK1 | 0.86325406 |
| 34 | PTK6 | 0.85550987 |
| 35 | PDK2 | 0.84530477 |
| 36 | GRK1 | 0.80569930 |
| 37 | CASK | 0.80074689 |
| 38 | EPHA3 | 0.78281089 |
| 39 | TAOK1 | 0.77473099 |
| 40 | SGK3 | 0.76190952 |
| 41 | TNIK | 0.75692243 |
| 42 | MAP3K12 | 0.74502596 |
| 43 | GRK7 | 0.74143001 |
| 44 | CAMKK2 | 0.73174759 |
| 45 | SGK1 | 0.72961353 |
| 46 | IRAK3 | 0.72742314 |
| 47 | RIPK1 | 0.68716711 |
| 48 | GSK3A | 0.66697354 |
| 49 | PDK3 | 0.65653524 |
| 50 | PDK4 | 0.65653524 |
| 51 | NTRK3 | 0.62722073 |
| 52 | PIK3CG | 0.61765978 |
| 53 | PDPK1 | 0.60840944 |
| 54 | MST1R | 0.60148571 |
| 55 | FRK | 0.60147663 |
| 56 | MELK | 0.59288473 |
| 57 | PRKCQ | 0.57996316 |
| 58 | YES1 | 0.57295101 |
| 59 | PIK3CA | 0.55623389 |
| 60 | RIPK4 | 0.54602268 |
| 61 | MAP2K7 | 0.50500298 |
| 62 | NEK6 | 0.50456636 |
| 63 | PINK1 | 0.48788455 |
| 64 | STK3 | 0.48727541 |
| 65 | TIE1 | 0.47974367 |
| 66 | PDK1 | 0.47810947 |
| 67 | MAPK7 | 0.46892614 |
| 68 | IRAK2 | 0.46361398 |
| 69 | MAP3K7 | 0.45316082 |
| 70 | CCNB1 | 0.45296670 |
| 71 | IRAK1 | 0.45008914 |
| 72 | PKN1 | 0.44334687 |
| 73 | MAP2K1 | 0.43243183 |
| 74 | BRD4 | 0.43225611 |
| 75 | LIMK1 | 0.42560886 |
| 76 | BMPR2 | 0.42409599 |
| 77 | PRKAA2 | 0.41554076 |
| 78 | AKT3 | 0.40099183 |
| 79 | PRKCE | 0.39517957 |
| 80 | PRKAA1 | 0.39025337 |
| 81 | MAP3K14 | 0.38730429 |
| 82 | KSR1 | 0.38667852 |
| 83 | AKT2 | 0.38196718 |
| 84 | PRKD2 | 0.38091731 |
| 85 | CAMK2B | 0.38075222 |
| 86 | PAK3 | 0.37149241 |
| 87 | NTRK1 | 0.36878420 |
| 88 | MAP2K4 | 0.36518785 |
| 89 | MAPKAPK3 | 0.36159929 |
| 90 | CDC42BPA | 0.35736236 |
| 91 | STK11 | 0.34244428 |
| 92 | TAOK3 | 0.34118928 |
| 93 | MAPK13 | 0.31541748 |
| 94 | ADRBK2 | 0.31430057 |
| 95 | ROCK1 | 0.31392504 |
| 96 | PRKACA | 0.31158799 |
| 97 | PRKCH | 0.31043203 |
| 98 | PTK2B | 0.30969598 |
| 99 | MAP3K1 | 0.29793832 |
| 100 | PRKG2 | 0.29441861 |
| 101 | JAK1 | 0.29409201 |
| 102 | PRKCG | 0.28141483 |
| 103 | PRKCZ | 0.27814273 |
| 104 | PRKCA | 0.26869466 |
| 105 | EIF2AK3 | 0.26688613 |
| 106 | CAMK2A | 0.24938032 |
| 107 | CDK5 | 0.24723791 |
| 108 | ABL2 | 0.24586708 |
| 109 | PRKCD | 0.24007879 |
| 110 | NEK9 | 0.23776309 |
| 111 | BRSK2 | 0.23582029 |
| 112 | CSNK1A1 | 0.23144289 |
| 113 | PTK2 | 0.21476909 |
| 114 | KSR2 | 0.21061668 |
| 115 | NME1 | 0.20372515 |
| 116 | OBSCN | 0.19861121 |
| 117 | DYRK1B | 0.19466712 |
| 118 | PRKACG | 0.18704096 |
| 119 | MINK1 | 0.18581849 |
| 120 | HIPK2 | 0.18403245 |
| 121 | CAMK4 | 0.18058419 |
| 122 | INSR | 0.18024929 |
| 123 | UHMK1 | 0.17249574 |
| 124 | TNK2 | 0.16997841 |
| 125 | BLK | 0.16974284 |
| 126 | EGFR | 0.16521141 |
| 127 | CDK3 | 0.16134677 |
| 128 | MET | 0.15808836 |
| 129 | DMPK | 0.15686751 |
| 130 | JAK2 | 0.15561291 |
| 131 | IRAK4 | 0.14980021 |
| 132 | CAMK2D | 0.14263660 |
| 133 | PRKD3 | 0.14051200 |
| 134 | FER | 0.13705229 |
| 135 | ADRBK1 | 0.13262419 |
| 136 | FGFR2 | 0.12933398 |
| 137 | FGFR4 | 0.12543849 |
| 138 | DYRK1A | 0.12462244 |
| 139 | PNCK | 0.12371953 |
| 140 | FES | 0.11917881 |
| 141 | MAP3K4 | 0.11198110 |
| 142 | CAMK2G | 0.10261461 |
| 143 | PRKG1 | 0.09900606 |
| 144 | RET | 0.09621978 |
| 145 | MAPK12 | 0.09584135 |
| 146 | GRK5 | 0.08873501 |
| 147 | SRC | 0.08748752 |
| 148 | NEK1 | 0.08558811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.65722548 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.43148966 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.28409881 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.06027127 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.05957602 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.95088307 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.88850356 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.59068359 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37857856 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.35958892 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.27285915 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.21757546 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 2.17727649 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98511606 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96617129 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86120984 |
| 17 | Mineral absorption_Homo sapiens_hsa04978 | 1.83864900 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83660309 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81477480 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81360373 |
| 21 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79841685 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.78008274 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.70306739 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61603055 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.60880537 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53764985 |
| 27 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.49223196 |
| 28 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.48592737 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.45087175 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40723430 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.38156222 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37563822 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.33814968 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.32512538 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28301819 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.28251897 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27258762 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24399860 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.18302820 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18005939 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17993683 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17644800 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05398759 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02033879 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97943878 |
| 46 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94101605 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93653045 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93381458 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92055315 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.91697350 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90507655 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85793556 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84651863 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84541181 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84446015 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84120616 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82869015 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81899695 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81553574 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80755367 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80634014 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79415077 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78858308 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78276277 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.78106717 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77521029 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.73254541 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72136719 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69136019 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68272946 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66970649 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64060596 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62715469 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61931905 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60494542 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 0.59231027 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58965280 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57771878 |
| 79 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54427999 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54366844 |
| 81 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.54087355 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53519384 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53461652 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53169966 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.52556131 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51346930 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51285883 |
| 88 | Phototransduction_Homo sapiens_hsa04744 | 0.50494179 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50082251 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49635114 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49291759 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48533579 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47848138 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47135188 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.46854400 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.46437604 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45960155 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45952453 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45393664 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.45166072 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43646343 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42381518 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41978095 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.41761297 |
| 105 | Nicotine addiction_Homo sapiens_hsa05033 | 0.41693091 |
| 106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.41231477 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40523445 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40507363 |
| 109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40203335 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.40082310 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39944841 |
| 112 | GABAergic synapse_Homo sapiens_hsa04727 | 0.38177694 |
| 113 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37721632 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37681191 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36403649 |
| 116 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36382270 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35731740 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34152357 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33707478 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32991580 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32238965 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30636733 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30032896 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27802968 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25929032 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25432962 |
| 127 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.24204304 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.23208326 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21263252 |
| 130 | Morphine addiction_Homo sapiens_hsa05032 | 0.18721427 |
| 131 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.18004732 |
| 132 | Renin secretion_Homo sapiens_hsa04924 | 0.17869937 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17396291 |
| 134 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.16440998 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.15411633 |

